Grandfield & Dodd, LLC
- SEC CIK
- 0001308016
- Latest filing
- Aug 7, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Grandfield & Dodd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,204
- Value
- $964.5K
- % of portfolio
- 0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,204 | $964.5K | 0.1% | +123+4.0% | Added | Holders |
| Q1 2026 | 3,081 | $1.02M | 0.1% | −48−1.5% | Reduced | Holders |
| Q4 2025 | 3,129 | $1.24M | 0.1% | +9+0.3% | Added | Holders |
| Q3 2025 | 3,120 | $1.42M | 0.1% | +68+2.2% | Added | Holders |
| Q2 2025 | 3,052 | $995.2K | 0.1% | +20+0.7% | Added | Holders |
| Q1 2025 | 3,032 | $818.7K | 0.1% | +659+27.8% | Added | Holders |
| Q4 2024 | 2,373 | $558.4K | <0.1% | +1,149+93.9% | Added | Holders |
| Q3 2024 | 1,224 | $336.6K | <0.1% | +1,224 | New | Holders |